Cormorant Asset Management, LP Bridge Bio Pharma, Inc. Transaction History

Cormorant Asset Management, LP

$992 Million
Q2 2025

A detailed history of Cormorant Asset Management, LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 1,600,000 shares of BBIO stock, worth $100 Million. This represents 6.97% of its overall portfolio holdings.

Number of Shares

1,600,000

Previous 2,000,000 20.0%

Holding current value

$100 Million

Previous $69.1 Million 0.08%

% of portfolio

6.97%

Previous 7.33%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$30.14 - $45.12 $12.1 Million - $18 Million	-400,000 Reduced 20.0%	1,600,000 $69.1 Million
Q1 2025 May 15, 2025	BUY	$28.12 - $37.59 $11.2 Million - $15 Million	400,000 Added 25.0%	2,000,000 $69.1 Million
Q4 2024 Feb 14, 2025	SELL	$22.35 - $29.5 $5.77 Million - $7.62 Million	-258,351 Reduced 13.9%	1,600,000 $43.9 Million
Q2 2024 Aug 14, 2024	SELL	$23.0 - $31.04 $30.9 Million - $41.7 Million	-1,344,678 Reduced 41.98%	1,858,351 $47.1 Million
Q1 2024 May 15, 2024	SELL	$27.35 - $40.45 $3.86 Million - $5.71 Million	-141,150 Reduced 4.22%	3,203,029 $99 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $31.7 Million - $57.9 Million	-1,318,351 Reduced 28.28%	3,344,179 $135 Million
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $8.33 Million - $17.3 Million	493,351 Added 11.83%	4,662,530 $123 Million
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $5.16 Million - $6.99 Million	-388,235 Reduced 8.52%	4,169,179 $71.7 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $22.9 Million - $59.1 Million	3,188,235 Added 232.86%	4,557,414 $75.6 Million
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $674,000 - $1.15 Million	-100,000 Reduced 6.81%	1,369,179 $10.4 Million
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $519,593 - $1.21 Million	-99,730 Reduced 6.36%	1,469,179 $13.3 Million
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $734,000 - $1.72 Million	-100,000 Reduced 5.99%	1,568,909 $15.9 Million
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $1.14 Million - $5.34 Million	-100,000 Reduced 5.65%	1,668,909 $27.8 Million
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $5.25 Million - $7.2 Million	-112,071 Reduced 5.96%	1,768,909 $82.9 Million
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $13.4 Million - $18.4 Million	-287,929 Reduced 13.28%	1,880,980 $115 Million
Q1 2021 May 17, 2021	SELL	$55.47 - $72.35 $5.37 Million - $7.01 Million	-96,853 Reduced 4.27%	2,168,909 $134 Million
Q3 2020 Nov 16, 2020	SELL	$27.2 - $42.19 $8.84 Million - $13.7 Million	-325,000 Reduced 12.54%	2,265,762 $85 Million
Q2 2020 Aug 14, 2020	SELL	$22.22 - $35.69 $7.98 Million - $12.8 Million	-359,238 Reduced 12.18%	2,590,762 $84.5 Million
Q1 2020 May 15, 2020	BUY	$16.11 - $36.23 $7.04 Million - $15.8 Million	437,135 Added 17.4%	2,950,000 $85.6 Million
Q4 2019 Feb 14, 2020	SELL	$17.96 - $46.63 $1.88 Million - $4.88 Million	-104,701 Reduced 4.0%	2,512,865 $88.1 Million
Q3 2019 Nov 14, 2019	SELL	$20.13 - $32.38 $3.29 Million - $5.29 Million	-163,319 Reduced 5.87%	2,617,566 $56.2 Million
Q2 2019 Aug 14, 2019	BUY	$26.97 - $27.55 $75 Million - $76.6 Million	2,780,885 New	2,780,885 $75 Million

Others Institutions Holding BBIO

# of Institutions

421

Shares Held

188M

Call Options Held

11.3M

Put Options Held

1.93M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $9.3B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account

Cormorant Asset Management, LP Bridge Bio Pharma, Inc. Transaction History